Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. - David P; Kouhestani D; Hansen FJ; Paul S; Czubayko F; Karabiber A; Weisel N; Klösch B; Merkel S; Ole-Baur J; Gießl A; Van Deun J; et al. (International journal of molecular sciences, 2025)